Skip to content
Iniparib
Iniparib is a small molecule pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
21 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
NeoplasmsD009369C805—1——6
Breast neoplasmsD001943EFO_0003869C50—31—15
Squamous cell neoplasmsD018307——1——1
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Brain neoplasmsD001932EFO_0003833C7111———2
Triple negative breast neoplasmsD064726—2———2
Ovarian neoplasmsD010051EFO_0003893C56—2———2
Male breast neoplasmsD018567—1———1
CarcinosarcomaD002296—1———1
GlioblastomaD005909EFO_000051511———1
Non-small-cell lung carcinomaD002289—1———1
Ovarian epithelial carcinomaD000077216—1———1
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameINIPARIB
INNiniparib
Description
4-iodo-3-nitrobenzamide is a carbonyl compound and an organohalogen compound.
Classification
Small molecule
Drug classpoly-ADP-ribose polymerase inhibitors
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
NC(=O)c1ccc(I)c([N+](=O)[O-])c1
Identifiers
PDB—
CAS-ID160003-66-7
RxCUI—
ChEMBL IDCHEMBL1170047
ChEBI ID—
PubChem CID9796068
DrugBankDB13877
UNII ID2ZWI7KHK8F (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 862 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
32 adverse events reported
View more details